skip to main content
Idioma:
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses
Material Type:
Artigo 		Adicionar ao Meu Espaço

High activity of sorafenib in FLT3-ITD-positive acute myeloid leukemia synergizes with allo-immune effects to induce sustained responses

METZELDER, S. K ; SCHROEDER, T ; HEINICKE, T ; STUHLMANN, R ; MÜLLER, L ; GIAGOUNIDIS, A ; MEYER, R. G ; BRUGGER, W ; VÖHRINGER, M ; DREGER, P ; MORI, M ; BASARA, N ; FINCK, A ; SCHÄFER-ECKART, K ; SCHULTHEIS, B ; BALDUS, C ; NEUBAUER, A ; BURCHERT, A ; SCHOLL, S ; FEY, M ; GÖTZE, K ; LINN, Y. C ; KRÖGER, M ; REITER, A ; SALIH, H. R

Leukemia, 2012-11, Vol.26 (11), p.2353-2359 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term survival of sorafenib-treated FLT3-ITD–positive acute myeloid leukaemia patients relapsing after allogeneic stem cell transplantation

Metzelder, S.K. ; Schroeder, T. ; Lübbert, M. ; Ditschkowski, M. ; Götze, K. ; Scholl, S. ; Meyer, R.G. ; Dreger, P. ; Basara, N. ; Fey, M.F. ; Salih, H.R. ; Finck, A. ; Pabst, T. ; Giagounidis, A. ; Kobbe, G. ; Wollmer, E. ; Finke, J. ; Neubauer, A. ; Burchert, A.

European journal of cancer (1990), 2017-11, Vol.86, p.233-239 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia
Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia

Burchert, A ; Saussele, S ; Eigendorff, E ; Müller, M C ; Sohlbach, K ; Inselmann, S ; Schütz, C ; Metzelder, S K ; Ziermann, J ; Kostrewa, P ; Hoffmann, J ; Hehlmann, R ; Neubauer, A ; Hochhaus, A

Leukemia, 2015-06, Vol.29 (6), p.1331-1335 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
4
NFATc1 as a therapeutic target in FLT3-ITD-positive AML
NFATc1 as a therapeutic target in FLT3-ITD-positive AML
Material Type:
Artigo 		Adicionar ao Meu Espaço

NFATc1 as a therapeutic target in FLT3-ITD-positive AML

Metzelder, S K ; Michel, C ; von Bonin, M ; Rehberger, M ; Hessmann, E ; Inselmann, S ; Solovey, M ; Wang, Y ; Sohlbach, K ; Brendel, C ; Stiewe, T ; Charles, J ; Ten Haaf, A ; Ellenrieder, V ; Neubauer, A ; Gattenlöhner, S ; Bornhäuser, M ; Burchert, A

Leukemia, 2015-07, Vol.29 (7), p.1470-1477 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Malignes“ ARDS
Malignes“ ARDS
Material Type:
Artigo 		Adicionar ao Meu Espaço

Malignes“ ARDS

Metzelder, S.K. ; Reinke, C. ; Walthers, E.M. ; Barth, P. ; Vogelmeier, C. ; Neubauer, A. ; Bals, R.

Der Internist (Berlin), 2009-10, Vol.50 (10), p.1272-1277

Berlin/Heidelberg: Springer-Verlag

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (4)

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.